Today: 21 March 2026
Subscribe
Browse Category

NASDAQ:MLYS 30 December 2025

Mineralys Therapeutics (MLYS) stock slides today as biotech weakens; FDA filing timeline in focus

Mineralys Therapeutics (MLYS) stock slides today as biotech weakens; FDA filing timeline in focus

Mineralys Therapeutics shares fell 3.3% to $35.61 by early afternoon Tuesday, underperforming biotech peers as investors awaited updates on its blood-pressure drug lorundrostat. The stock remains up 183% over 52 weeks but is down 25% from its November high. Mineralys plans to file for FDA approval of lorundrostat by early 2026 and expects Phase 2 results in the first quarter of that year.
30 December 2025
··

Stock Market Today

  • Firm Capital Property Trust TSX:FCD.UN Offers 8.7% Dividend with Monthly Cash Payout
    March 20, 2026, 11:02 PM EDT. Firm Capital Property Trust (TSX:FCD.UN) trades at a $220 million market cap, offering an 8.7% dividend yield with monthly payouts, attracting income-focused investors. The trust owns 62 Canadian commercial properties plus residential units, with nearly half its net operating income from stable grocery-anchored retail locations. Its adjusted funds from operations (AFFO) payout ratio improved to 98% in Q4 2025, down from over 100%, signaling better dividend sustainability. Management's conservative debt level at 50% of gross book value supports resilience amid interest rate pressures. Shares trade at a 25% discount to net asset value, highlighting potential value amid cautious market sentiment.
Go toTop